We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in ourCookies Policy. By using this website you agree to our use of cookies.

The item you have requested is not currently available in English and you have been redirected to the next available page. You may use your browser's back button to return to the item you were viewing.

On 16 November 2016 the Sejm (lower chamber of the Parliament) adopted a bill to amend the VAT Act and certain other statutory laws, calling for numerous changes in the VAT Act and the Criminal Fiscal Code, among other laws.

With 125+ locations in 50+ countries, Dentons is home to top-tier talent that is found at the intersection of geography, industry knowledge and substantive legal experience. Working with Dentons, you will have the opportunity to learn from the best lawyers in the industry at the largest law firm in the world.

Dentons is proud to congratulate our six lawyers who are listed as “Canada’s Leading Litigation Lawyers” by Lexpert, in its 2016 special edition that profiles Lexpert-ranked lawyers in several areas of business-related litigation.

Dentons Rodyk & Davidson LLP, part of the world’s largest law firm, Dentons, is pleased to announce that John Dick has joined the Firm as part of its Energy, Resources and Infrastructure practice and its South East Asia regional practice.

Adam OdojewskiSenior Associate

More information...

Experience

Activities and Affiliations

Areas of focus

Education

Admissions and qualifications

Languages

Adam Odojewski is a senior associate in Dentons’ Warsaw office and a member of Litigation and Arbitration practice team. He specializes in legal advice for healthcare companies and companies connected with the medical sector in the wider sense.

In particular, he advises on matters covered by pharmaceutical law and laws governing medicinal products, with particular emphasis on regulations applicable to reimbursement and state financing of healthcare services. He was involved in the comprehensive preparation by pharmaceutical companies to comply with the new reimbursement law that came into force in Poland in 2012.

Adam also specializes in civil and commercial law. He is actively involved in representing clients in court disputes, among other things concerning advertisement law, unfair competition law and protection of personal rights law. Furthermore, he has experience in obtaining interim injunctions.

Experience

Comprehensive legal and litigation assistance to an innovative insurance operator belonging to the top Polish wholesale and retail drug distribution group with regard to a massive challenge conducted against the client’s business model by Polish pharmacy chambers and regulatory authorities. The assistance covered numerous administrative cases and a civil court dispute as well.

Representing a top pharmaceutical MNC in a court dispute against its competitor connected with a controversial advertisement campaign where specific features of the client’s product, were questioned in a counter-campaign by the competitor. An interim injunction was obtained preventing the competitor from continuing the counter-campaign referring to the client’s product in the previous offensive way.

Representing International Telecom Group in a complex court dispute valued at approx. PLN 70 million against the top Polish telecom company, including working on a lawsuit and obtaining a 100% successful interim injunction to the benefit of the client.

Advising on structuring a clinical trial agreement for the leading CRO in Europe (including coordination of the project involving a U.S. based sponsor, EU based representative and a local institution as the trial site).

Advising several top pharmaceutical MNCs in preparation for the major reimbursement law reform that came into force in 2012 in Poland, including assessment of expected legal impact of the new law on the client’s business model, products portfolio, marketing tools and other relevant areas.

Languages

Disclaimer

Unsolicited emails and other information sent to Dentons will not be considered confidential, may be disclosed to others, may not receive a response, and do not create a lawyer-client relationship. If you are not already a client of Dentons, please do not send us any confidential information.